If you research the GLP compounds, cagrisema and retatrutide are two names you keep running into, and they get treated as if they are the same kind of thing. They are not. They are built differently, and after the 2026 vendor shakeout the more useful comparison is not which is newer. It is which one you can actually source with paperwork behind it.
Here is how the two line up.
Class and structure
The clearest difference is how each compound is put together. Cagrisema is a two-part research combination. It pairs cagrilintide, an amylin analog, with semaglutide, a GLP-1 receptor agonist. Retatrutide is a single peptide and a triple receptor agonist, described in the literature as targeting the GLP-1, GIP, and glucagon receptors at once.
So one is a blend of two mechanisms in a single vial, and the other is one molecule engineered to hit three targets. This is a structural difference, not a ranking. The right compound for a lab depends entirely on the research question.
Side by side
| Factor | Cagrisema | Retatrutide |
|---|---|---|
| Type | Two-peptide research combination | Single peptide |
| Components | Cagrilintide plus semaglutide | One molecule |
| Class | Amylin analog plus GLP-1 agonist | Triple receptor agonist |
| Receptor targets | Amylin and GLP-1 | GLP-1, GIP, and glucagon |
| Documentation | Per batch COA, mass spec | Per batch COA, mass spec |
| Purity | HPLC verified ninety nine percent or higher | 99.579% HPLC on recent lots |
| Sourcing | Order online, same-day local pickup | Order online, same-day local pickup |
Both are research-use-only compounds, studied in laboratory and animal models, not for human or veterinary use. For the wider GLP picture, the retatrutide, tirzepatide, and semaglutide comparison breaks the class down by receptor target.
Sourcing is the real comparison
Class and structure are settled facts. Sourcing is where researchers get burned. Both of these compounds were prime counterfeit targets during the shakeout, so for either one you want a per batch Certificate of Analysis you can read before you buy, HPLC purity on the specific lot, mass spectrometry confirmation, and a lot number tied to your vial.
Retatrutide is the compound with a confirmed reading to point at. Recent lots have come back at 99.579% HPLC verified purity, which is a number off a real lot rather than a round marketing figure. Cagrisema carries HPLC verified purity of ninety nine percent or higher on every batch. Both are tested through Janoshik, and you can see the COA on each before ordering.
For researchers in Los Angeles and Orange County, both are available for same-day local pickup or shipping. Compare the two product pages, check the paperwork, and buy the one your research calls for.
All products are for laboratory research only. Not for human or veterinary use.
Research Use Only
This article is provided for educational purposes. All peptides discussed are sold for research use only and are not intended for human consumption or therapeutic use.